Barber, Paul R <br/><br/>
HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial.  [electronic resource] 

 -  Journal of the National Cancer Institute  09 2020 
 - 944-954 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djz231  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--diagnosis<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bayes Theorem<br/>Capecitabine--therapeutic use<br/>Cohort Studies<br/>Colorectal Neoplasms--diagnosis<br/>Female<br/>Fluorescence Resonance Energy Transfer<br/>Humans<br/>Latent Class Analysis<br/>Male<br/>Microscopy--methods<br/>Middle Aged<br/>Oxaloacetates--therapeutic use<br/>Prognosis<br/>Protein Multimerization<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Receptor, ErbB-2--analysis<br/>Receptor, ErbB-3--analysis<br/>Tissue Array Analysis<br/>Treatment Outcome